Did FDA Fully Analyse Pfizer Trial Data in 22 Days? Impossible, Says Expert

FDA claims it fully analysed the individual participant data (IPD) underpinning the emergency authorisation of Pfizer’s covid-19 vaccine in only 22 days. Experts say the agency must have cut corners.

In 2020, governments around the world imposed brutal lockdowns across the population, promising a safe and effective covid-19 vaccine was just around the corner.

The Trump administration made no secret of the fact that it wanted the Food and Drug Administration (FDA) to hurry the process along.

Stephen Hahn, then FDA commissioner, was summoned to the White House and asked to explain why he hadn’t moved faster to approve Pfizer’s Covid-19 vaccine.

Continue Reading